Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03732677
Brief Title: Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC (NIAGARA)

First Submitted : October 5, 2018
First Submitted that Met QC Criteria : November 5, 2018
First Posted : November 6, 2018

Last Update Submitted that Met QC Criteria : September 27, 2019
Last Update Posted : September 30, 2019